AARP's Recommendations to Combat Medicare Fraud with AI Solutions
AARP recently submitted a strategic set of recommendations to federal health officials aimed at curbing fraud and enhancing accountability within Medicare, Medicaid, and the broader health insurance marketplace. These proposals focus on leveraging AI-driven solutions to address fraudulent billing, reducing the timeframe for providers to file Medicare claims, ensuring equitable payments within Medicare Advantage, and curtailing misleading advertising by medical product suppliers.
AARP, representing 125 million Americans aged 50 and over, expressed concerns that some anti-fraud measures might introduce unnecessary barriers to care and coverage for legitimate beneficiaries. Megan O'Reilly, AARP’s vice president for health and family issues, emphasized that individuals should not suffer from fraud prevention strategies that impede access to essential services or introduce bureaucratic obstacles compromising their well-being.
In response to a call from the Centers for Medicare & Medicaid Services (CMS) for ideas to combat abuse, fraud, and waste, AARP insisted that fraud elimination efforts must precisely target wrongdoers without impeding necessary care for enrollees. This response comes amid increased scrutiny surrounding the withholding of $259 million in Medicaid funds from Minnesota due to questionable claims, and the nationwide suspension of new durable medical equipment providers’ enrollment in Medicare due to concerns over fraudulent billing practices.
AARP supports enhancing CMS's oversight by requiring that Medicare Advantage participants enroll in original Medicare, facilitating more efficient fraud detection. While existing regulatory compliance frameworks are in place, AARP acknowledges that their enforcement is challenged by resource constraints, highlighting the need for more robust implementation.
A CMS pilot program underway in six states addresses unnecessary costs by mandating prior authorization for 13 procedures and services in original Medicare. While prior authorization is common in Medicare Advantage, its expansion into original Medicare has sparked concerns over potential misuse. AARP opposes this expansion, fearing unjust care denial and incentivization of claim denials based on savings by technology companies—conflicts that may detract from patient care priorities.
The pilot affects beneficiaries in Oklahoma, Texas, Arizona, Washington, Ohio, and New Jersey, impacting only those referred for specified procedures. AARP warns against remuneration models rewarding technology companies solely based on claim denials, advocating for the ethical use of AI in identifying improper payments without substituting clinical judgments or penalizing patients due to provider fraud.